Regional and Whole-Body Dual-Energy X-Ray Absorptiometry to Guide Treatment and Monitor Disease Progression in Neuromuscular Disease

Physical Medicine and Rehabilitation Clinics of North America

Volumn 23, Issue 1, 2012, Pages 67-73

  Skalsky, Andrew J ^a   Han, Jay J ^b   Abresch, Richard T ^b   McDonald, Craig M ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body composition; DEXA; Fat mass; Lean mass

Indexed keywords

CORTICOSTEROID;

BODY COMPOSITION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; DUCHENNE MUSCULAR DYSTROPHY; ENERGY EXPENDITURE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MUSCLE MASS; MUSCLE WEAKNESS; NEUROMONITORING; NEUROMUSCULAR DISEASE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SPINAL MUSCULAR ATROPHY;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; BODY COMPOSITION; DIET; DISEASE PROGRESSION; HUMANS; NEUROMUSCULAR DISEASES;

EID: 84855723024     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2011.11.007     Document Type: Review

References (20)

1. Gilsanz V. Bone density in children: a review of the available techniques and indications. Eur J Radiol 1998, 26(2):177-182.
2. Ross R. Advances in the application of imaging methods in applied and clinical physiology. Acta Diabetol 2003, 40(Suppl 1):S45-S50.
3. McDonald C.M., Carter G.T., Abresch R.T., et al. Body composition and water compartment measurements in boys with Duchenne muscular dystrophy. Am J Phys Med Rehabil 2005, 84:483-491.
4. Mok E., Letellier G., Cuisset J.M., et al. Assessing change in body composition in children with Duchenne muscular dystrophy: anthropometry and bioelectrical impedance analysis versus dual-energy X-ray absorptiometry. Clin Nutr 2010, 29(5):633-638.
5. Wang W., Wang Z., Faith M.S., et al. Regional skeletal muscle measurement: evaluation of new dual-energy X-ray absorptiometry model. JAppl Physiol 1999, 87:1163-1171.
6. Snyder W.S., Cook M.J., Nasset E.S., et al. Report of the task group on reference man 1975, Pergamon Press, Oxford (UK).
7. Boesch C., Slotboom J., Hoppeler H., et al. Invivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 1997, 37:484-493.
8. Constantinides C.D., Gillen J.S., Boada F.E., et al. Human skeletal muscle: sodium MR imaging and quantification-potential applications in exercise and disease. Radiology 2000, 216(2):559-568.
9. Forbes G.B., Griggs R.C., Moxley R.T., et al. K-40 and dual-energy X-ray absorptiometry estimates of lean weight compared. Normals and patients with neuromuscular disease. Ann N Y Acad Sci 2000, 904:111-114.
10. Kissel J.T., McDermott M.P., Mendell J.R., FSH-DY Group, et al. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 2001, 57(8):1434-1440.
11. Pruna L., Chatelin J., Pascal-Vigneron V., et al. Regional body composition and functional impairment in patients with myotonic dystrophy. Muscle Nerve 2011, 44(4):503-508.
12. Skalsky A.J., Abresch R.T., Han J.J., et al. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord 2008, 18(11):873-880.
13. Skalsky A.J., Han J.J., Abresch R.T., et al. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Muscle Nerve 2009, 39(5):647-651.
14. Palmieri M.D., Bertorini M.D., Griffin J.W., et al. Assessment of whole body composition with dual energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of lean body mass with muscle function. Muscle Nerve 1996, 19:777-779.
15. Gonzalez-Bermejo J., Lofaso F., Falaize L., et al. Resting energy expenditure in Duchenne patients using home mechanical ventilation. Eur Respir J 2005, 25(4):682-687.
16. Wang C.H., Finkel R.S., Bertini E.S., Participants of the International Conference on SMA Standard of Care, et al. Consensus statement for standard of care in spinal muscular atrophy. JChild Neurol 2007, 22(8):1027-1049.
17. Shimizu-Fujiwara M., Komaki H., Nakagawa E., et al. Decreased resting energy expenditure in patients with Duchenne muscular dystrophy. Brain Dev 2011, [Epub ahead of print].
18. Zanardi M.C., Tagliabue A., Orcesi S., et al. Body composition and energy expenditure in Duchenne muscular dystrophy. Eur J Clin Nutr 2003, 57(2):273-278.
19. Hankard R., Gottrand F., Turck D., et al. Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res 1996, 40(1):29-33.
20. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9(1):77-93. [review].